Results 231 to 240 of about 34,947 (279)
Some of the next articles are maybe not open access.
Myocardial Metabolic Reprogramming in HFpEF
Journal of Cardiovascular Translational Research, 2023Heart failure (HF) caused by structural or functional cardiac abnormalities is a significant cause of morbidity and mortality worldwide. While HF with reduced ejection fraction (HErEF) is well understood, more than half of patients have HF with preserved ejection fraction (HFpEF).
Zihui Zhang +5 more
openaire +2 more sources
Current Treatment Options in Cardiovascular Medicine, 2020
Heart failure with preserved ejection fraction (HFpEF) disproportionately affects women. Though no unifying theory exists to explain this phenomenon, the purpose of this review is to explore the many factors that likely contribute to this female predominance.
Anna C. O’Kelly, Emily S. Lau
openaire +1 more source
Heart failure with preserved ejection fraction (HFpEF) disproportionately affects women. Though no unifying theory exists to explain this phenomenon, the purpose of this review is to explore the many factors that likely contribute to this female predominance.
Anna C. O’Kelly, Emily S. Lau
openaire +1 more source
HFpEF treatment: pharmacological therapy
2018Heart failure with preserved ejection fraction (HFpEF) is a diverse syndrome characterized by signs and symptoms of heart failure with relatively preserved ejection fraction. Despite the established efficacy of numerous classes of drugs and devices in heart failure with reduced ejection fraction, no specific therapy has yet proven to reduce morbidity ...
Maja Cikes, Scott D. Solomon
openaire +1 more source
Neuromodulation reduces inflammation in HFpEF
Nature Reviews Cardiology, 2022openaire +2 more sources
Targeting Mitochondria-Inflammation Circuit by β-Hydroxybutyrate Mitigates HFpEF
Circulation Research, 2021Yan Deng, Qian Li, Xuewen Xu
exaly